Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review

doi:10.5306/wjco.v11.i1.31

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 1

This Article

(275)

(402)

(0)

(1)

(10779)

(49)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Systematic Review

World J Clin Oncol. Jan 24, 2020; 11(1): 31-42
Published online Jan 24, 2020. doi: 10.5306/wjco.v11.i1.31

Table 1 Presence of B-raf proto-oncogene serine/threonine kinase and B-raf proto-oncogene serine/threonine kinase V600E and the relation with additional mutations

BRAF type	Ameloblastoma			Histological pattern	Mutations	Additional mutation	Anatomic location
	Type	Cases with expression	Total cases	Histological pattern (cases)	Gene (cases/total)	Gene (cases)	Site (cases)
BRAF WT	Ameloblastoma	39	521	Follicular (15)	NRAS Q161R (2/15)		Mandible (9)
							Maxilla (1)
					G606E (1/15)		NS (5)
					L584P, V590G (1/15)
				Plexiform (14)	HRASQ161R (2/14)		Mandible (10)
					FGFR2 p.C382R (2/14)		Maxilla (1)
							NS (3)
				Mixed (4)			Mandible (4)
				NS (6)	FGFR2 (4/12)	PTEN, TP53 (1)	NS (6)
					KRAS (1/12)
	Unicystic ameloblastoma	10	81	Luminal/intraluminal (6)			Mandible (4)
							Maxilla (2)
				NS (4)			Mandible (1)
							NS (3)
	Ameloblastic carcinoma	7	13	Without cell variant (5)			Mandible (3)
							Maxilla (2)
				NS (2)			NS (2)
	Metastasizing ameloblastoma	0	2
BRAF V600E	Ameloblastoma	297	521	Follicular (121)			Mandible (91)
					JAK3 P132T (3/121)
					SMARCB1 (1/121
					PIK3CA (1/121)
					CTNNB1 (1/121)
					SMO (1/121)
					SMO (1/121)	FGFR2 (1)	Maxilla (4)
							Left frontal bone (1)
					G606E (2/121)		NS (25)
				Plexiform (65)	JAK3 P132T (1/65)		Mandible (38)
					SMARCB1 (1/65)
					PIK3CA (1/65)
					PIK3CA (1/65)		Maxilla (2)
					BRAF 597R (1/65)	SMO (1)
							NS (25)
				No follicular (20)			Mandíbula (20)
				No plexiform (15)			NS (15)
				Granular-cell (4)			Mandible (4)
				Mixted (10)			Mandible (4)
							NS (6)
				Without cell variant (1)			Mandible (1)
				Desmoplastic (2)			Mandible (1)
							Maxilla (1)
				NS (59)	FGF2¹ (23)		Mandible (4)
					FGFR1¹ (24)		Maxilla (1)
							NS (45)
							Cavernus sinus (1)
							Coronoid process (1)
	Unicistyc ameloblastoma	63	81	Luminal/Intraluminal (21)			Mandible (19)
							Maxilla (2)
				Mural (20)			Mandible (20)
				NS (22)			Mandible (12)
							Maxilla (1)
							NS (9)
	Peripheral ameloblastoma	5	6	NS (5)			NS (5)
	Ameloblastic carcinoma	3	13	Without cell variant (3)			Mandible (3)
	Metastasizing	1	2	Follicular (1)			Mandible (1)
	NS			Acanthomatous (7)			Mandible (7)
				Granular cells (2)			Mandible (2)
				NS (2)	PIK3CA, CDKN2A (1)		Mandible (1)
					PIK3CA, PTEN (1)		Mandible (1)
				NS (2)	CDKN2A (1)		Mandible (1)
					CTNNB1 (1)		Mandible (1)
No mutations	Metastasizing Ameloblastoma	1	2	Plexiform (1)			Infratemporal fosa (1)
	Ameloblastic Carcinoma	3	13	NS (3)			NS (3)
	Unicistyc Ameloblastoma	1	81				NS (1)

¹Expressed without mutation. NS: No specified; BRAF: B-raf proto-oncogene serine/threonine kinase; BRAF WT: B-raf proto-oncogene serine/threonine kinase Wild-type.

Full Size Table

Citation: González-González R, López-Verdín S, Lavalle-Carrasco J, Molina-Frechero N, Isiordia-Espinoza M, Carreón-Burciaga RG, Bologna-Molina R. Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review. World J Clin Oncol 2020; 11(1): 31-42
URL: https://www.wjgnet.com/2218-4333/full/v11/i1/31.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i1.31

González-González R, López-Verdín S, Lavalle-Carrasco J, Molina-Frechero N, Isiordia-Espinoza M, Carreón-Burciaga RG, Bologna-Molina R. Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review. World J Clin Oncol 2020; 11(1): 31-42 [PMID: 31976308 DOI: 10.5306/wjco.v11.i1.31]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.